Reaction of [Ru(arene)Cl(2)](2) (arene = benzene, toluene, p-cymene, hexamethylbenzene) with K(7)[PW(11)O(39)].14H(2)O provided two series of organometallic derivatives of heteropolytungstates: type-1 and type-2 complexes of general formulas [PW(11)O(39){Ru(arene)(H(2)O)}](5-) and [{PW(11)O(39){Ru(arene)}}(2){WO(2)}](8-), respectively. All compounds were characterized by infrared and multinuclear NMR ((1)H, (31)P, (183)W) spectroscopies. The crystal structures of Na(4)K(4)[{PW(11)O(39){Ru(benzene)}}(2){WO(2)}].6H(2)O (NaK-2a.6H(2)O), K(7)H[{PW(11)O(39){Ru(toluene)}}(2){WO(2)}].4H(2)O (K-2b.4H(2)O), and Cs(3)K(2)[PW(11)O(39){Ru(p-cymene)(H(2)O)}].4H(2)O (CsK-1c.4H(2)O) were obtained and revealed that the {Ru(arene)} fragment is supported on the oxometallic framework. Photochemical reactivity of [PW(11)O(39){Ru(arene)(H(2)O)}](5-) (arene = toluene, p-cymene) in the presence of various ligands L (L = H(2)O, dimethyl sulfoxide, tetramethylene sulfoxide, and diphenyl sulfoxide) was investigated, and led to the formation of [PW(11)O(39){Ru(L)}](5-), in which the ruthenium is incorporated into the lacunary [PW(11)O(39)](7-) anion.
No takes yet. Share an insight, caveat, or question.
Artero et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: